PharmaShots | Incisive News in 3 Shots

Subscribe Now

Dialectic

$Dialectic’s DT2216 Receives the US FDA’s Fast Track Designation for Relapsed or Refractory Peripheral and Cutaneous T-Cell Lymphoma$

Dialectic’s DT2216 Receives the US FDA’s Fast Track Designation for Relapsed or Refractory Peripheral and Cutaneous T-Cell Lymphom...

April 6, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us